Comparative Effectiveness of Abatacept Versus Subsequent Anti-TNF Agents Among Rheumatoid Arthritis Patients with Previous Anti-TNF Exposure.

被引：0
|
作者：
Harrold, Leslie R. [1 ]
Reed, George [1 ]
Curtis, Jeffrey R. [2 ]
Solomon, Daniel H. [3 ]
Hochberg, Marc [4 ]
Onofrei, Alina U. [1 ]
Kremer, Joel M. [5 ,6 ]
Greenberg, Jeffrey D. [7 ]
机构：
[1] UMass Med Sch, Worcester, MA USA
[2] Univ Alabama, Birmingham, AL USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[5] Ctr Rheumatol, Albany, NY USA
[6] Albany Med Coll, Albany, NY 12208 USA
[7] NYU, Sch Med, New York, NY USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2595
引用
收藏
页码：S1019 / S1019
页数：1
相关论文
共 50 条
  • [1] ECONOMIC EVALUATION OF RITUXIMAB VERSUS ANTI-TNF IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PREVIOUS FAILURE TO ANTI-TNF IN MEXICO
    Carlos, F.
    Clark, P.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A563 - A563
  • [2] Anti-TNF agents for rheumatoid arthritis
    Seymour, HE
    Worsley, A
    Smith, JM
    Thomas, SHL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 201 - 208
  • [3] THE COMPARATIVE EFFECTIVENESS OF TOCILIZUMAB AS COMPARED TO ABATACEPT IN THOSE WITH PRIOR EXPOSURE TO ANTI-TNF AGENTS
    Harrold, L. R.
    Reed, G. W.
    Solomon, D. H.
    Curtis, J. R.
    Liu, M.
    Greenberg, J. D.
    Kremer, J. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 138 - 138
  • [4] CLINICAL EFFECTIVENESS AND INFECTION RATE IN RHEUMATOID ARTHRITIS PATIENTS SWITCHED FROM ANTI-TNF AGENTS TO ABATACEPT
    Pietrosanti, M.
    Di Rosa, R.
    Salemi, S.
    Markovic, M.
    Carusi, V.
    Biondo, M. I.
    Catoni, M.
    Lagana, B.
    Sorgi, M. L.
    D'Amelio, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 888 - 888
  • [5] Rheumatoid Arthritis - Anti-TNF
    Chaabo, Khaldoun
    Kirkham, Bruce
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (02) : 180 - 184
  • [6] Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis
    Johnston, Stephen S.
    Turpcu, Adam
    Shi, Nianwen
    Fowler, Robert
    Chu, Bong-Chul
    Alexander, Kimberly
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (01) : 39 - 47
  • [7] Anti-TNF therapy in rheumatoid arthritis
    Meyer, O
    [J]. PRESSE MEDICALE, 2000, 29 (09): : 463 - 468
  • [8] Anti-TNF in rheumatoid arthritis: an overview
    Radner, Helga
    Aletaha, Daniel
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 2015, 165 (1-2) : 3 - 9
  • [9] Anti-TNF Treatment in Rheumatoid Arthritis
    Geiler, Janina
    Buch, Maya
    McDermott, Michael F.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (29) : 3141 - 3154
  • [10] Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
    Fragoulakis, Vasilis
    Vitsou, Elli
    Hernandez, Ana Cristina
    Maniadakis, Nikolaos
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 85 - 93
12345